Genialis and Debiopharm Collaborate to Advance DNA Damage Repair Drug Development with Cutting-Edge Biomarkers and AI Solutions
Key Highlights Genialis and Debiopharm join forces to develop predictive biomarkers for DDR-directed therapies, aiming to enhance patient-specific treatment effectiveness. The…
